Trials / Unknown
UnknownNCT04622748
Neurocognitive Functions of Recovered COVID-19 Patients
An Investigation of Neurocognitive Functions and the Influencing Factors in Recovered Patients With COVID-19
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 160 (estimated)
- Sponsor
- National Institute on Drug Dependence, China · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study is carried on in Wuchang Hospital in Wuhan, China. The investigators plan to recruit 80 patients with COVID-19 and 80 matched healthy control. Using the design of case-control study, the study aims to assess the neurocognitive functions such as executive function and attentional bias in recovered patients with COVID-19 under normal and stress conditions, and to analyze the influencing factors of neurocognitive functions, such as mental health conditions, inflammation indicators and cardiopulmonary function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Trier Social Stress Test | 8-min oral calculation and 5-min speech |
Timeline
- Start date
- 2020-07-10
- Primary completion
- 2020-12-10
- Completion
- 2020-12-10
- First posted
- 2020-11-10
- Last updated
- 2020-11-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04622748. Inclusion in this directory is not an endorsement.